Mc Adam, LLC Axsome Therapeutics, Inc. Transaction History

Mc Adam, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	SELL	$41.2 - $101.31 $87,096 - $214,169	-2,114 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$16.71 - $106.24 $35,324 - $224,591	2,114 New	2,114 $219,000
Q4 2018 Jan 30, 2019	SELL	$2.0 - $4.15 $4,000 - $8,300	-2,000 Closed	0 $0
Q2 2018 Aug 22, 2018	BUY	$2.15 - $3.6 $4,300 - $7,200	2,000 New	2,000 $6,000

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.16B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Mc Adam, LLC, based on Form 13F filings with the SEC.

Stay updated on Mc Adam, LLC with notifications on news.